ZA200803882B - Transdermal Therapeutic System - Google Patents
Transdermal Therapeutic SystemInfo
- Publication number
- ZA200803882B ZA200803882B ZA200803882A ZA200803882A ZA200803882B ZA 200803882 B ZA200803882 B ZA 200803882B ZA 200803882 A ZA200803882 A ZA 200803882A ZA 200803882 A ZA200803882 A ZA 200803882A ZA 200803882 B ZA200803882 B ZA 200803882B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic system
- transdermal therapeutic
- transdermal
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74151105P | 2005-12-01 | 2005-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200803882B true ZA200803882B (en) | 2009-03-25 |
Family
ID=37716856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200803882A ZA200803882B (en) | 2005-12-01 | 2008-05-07 | Transdermal Therapeutic System |
Country Status (31)
Country | Link |
---|---|
US (3) | US20070128263A1 (ja) |
EP (5) | EP2292219B9 (ja) |
JP (3) | JP2009517468A (ja) |
KR (7) | KR20220156666A (ja) |
CN (2) | CN101312717A (ja) |
AR (2) | AR057152A1 (ja) |
AT (1) | AT11185U1 (ja) |
AU (1) | AU2006320919B2 (ja) |
BR (2) | BRPI0619758A2 (ja) |
CA (1) | CA2563110A1 (ja) |
DE (2) | DE202006021172U1 (ja) |
DK (5) | DK2292219T3 (ja) |
EC (1) | ECSP088469A (ja) |
ES (1) | ES2414455T3 (ja) |
GT (1) | GT200800075A (ja) |
HK (1) | HK1153646A1 (ja) |
IL (4) | IL191311A (ja) |
MA (1) | MA30022B1 (ja) |
MY (2) | MY151020A (ja) |
NO (1) | NO20082753L (ja) |
NZ (1) | NZ568273A (ja) |
PH (2) | PH12013500771A1 (ja) |
PL (1) | PL2292219T4 (ja) |
PT (1) | PT2292219E (ja) |
RU (1) | RU2450805C2 (ja) |
SG (1) | SG2014014989A (ja) |
SI (1) | SI2292219T1 (ja) |
TN (1) | TNSN08238A1 (ja) |
TW (1) | TWI389709B (ja) |
WO (1) | WO2007064407A1 (ja) |
ZA (1) | ZA200803882B (ja) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI389709B (zh) | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
GB0823554D0 (en) | 2008-12-24 | 2009-01-28 | Novartis Ag | Process for the preparation of optically active compounds using transfer hydrogenation |
BRPI1006655A2 (pt) * | 2009-04-17 | 2016-02-10 | 3M Innovative Properties Co | construção de adesivo de gel de silicone e métodos para a produção de uma construção de adesivo de gel de silicone |
WO2010129689A1 (en) * | 2009-05-05 | 2010-11-11 | Forest Laboratories Holdings Limited | Milnacipran formulations |
PL2493457T3 (pl) | 2009-10-30 | 2018-01-31 | Ix Biopharma Ltd | Szybko rozpuszczalna stała postać dawkowana |
WO2011073362A1 (en) | 2009-12-18 | 2011-06-23 | Novartis Ag | Process for the preparation of optically active compounds using pressure hydrogenation |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
PL2515886T3 (pl) * | 2009-12-22 | 2018-08-31 | Luye Pharma Ag | Przezskórny układ terapeutyczny do podawania rywastygminy lub jej pochodnych |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
RU2578971C2 (ru) * | 2010-06-17 | 2016-03-27 | Лтс Ломанн Терапи-Системе Аг | Трансдермальное введение мемантина |
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
JP2013537526A (ja) * | 2010-07-21 | 2013-10-03 | スリーエム イノベイティブ プロパティズ カンパニー | 経皮接着剤組成物、デバイス、及び方法 |
WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
US20120046383A1 (en) * | 2010-08-19 | 2012-02-23 | Terumo Kabushiki Kaisha | Silicone rubber composition |
DK3590949T3 (da) | 2010-10-01 | 2022-07-11 | Modernatx Inc | Ribonukleinsyrer indeholdende n1-methyl-pseudouracil og anvendelse heraf |
EP2468274B1 (de) * | 2010-12-14 | 2015-07-01 | Acino AG | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
KR101788802B1 (ko) * | 2010-12-24 | 2017-10-20 | 주식회사 삼양바이오팜 | 리바스티그민을 함유하는 경피흡수제제 |
KR101054317B1 (ko) * | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
KR101317158B1 (ko) * | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
US8710200B2 (en) | 2011-03-31 | 2014-04-29 | Moderna Therapeutics, Inc. | Engineered nucleic acids encoding a modified erythropoietin and their expression |
KR20120130073A (ko) * | 2011-05-20 | 2012-11-28 | 에스케이케미칼주식회사 | 리바스티그민 함유 패취 |
WO2012161489A2 (ko) * | 2011-05-20 | 2012-11-29 | 에스케이케미칼 주식회사 | 리바스티그민 함유 패취 |
JP6102739B2 (ja) | 2011-08-31 | 2017-03-29 | 東洋インキScホールディングス株式会社 | 貼付剤 |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
RU2648950C2 (ru) | 2011-10-03 | 2018-04-02 | Модерна Терапьютикс, Инк. | Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US20130156849A1 (en) | 2011-12-16 | 2013-06-20 | modeRNA Therapeutics | Modified nucleoside, nucleotide, and nucleic acid compositions |
KR101399035B1 (ko) * | 2011-12-22 | 2014-05-28 | 주식회사 트랜스덤 | 리바스티그민을 함유하는 경피흡수제제 |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
CN104136025B (zh) * | 2012-02-28 | 2017-10-24 | 日绊株式会社 | 贴附剂 |
WO2013142339A1 (en) | 2012-03-23 | 2013-09-26 | Novartis Ag | Transdermal therapeutic system and method |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
WO2013151667A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides |
US9303079B2 (en) | 2012-04-02 | 2016-04-05 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US20150051559A1 (en) * | 2012-04-05 | 2015-02-19 | Sparsha Pharma International Private Limited | Transdermal patch for treatment of dementia or alzheimer type dementia |
WO2013187451A1 (ja) * | 2012-06-12 | 2013-12-19 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CN104582693A (zh) * | 2012-08-15 | 2015-04-29 | 道康宁公司 | 多层药物递送系统 |
CN104602687A (zh) * | 2012-09-03 | 2015-05-06 | 尼普洛外用药品株式会社 | 贴剂 |
KR20140038237A (ko) * | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
WO2014051128A1 (ja) * | 2012-09-28 | 2014-04-03 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
RS63237B1 (sr) | 2012-11-26 | 2022-06-30 | Modernatx Inc | Terminalno modifikovana rnk |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
RU2560668C2 (ru) * | 2013-03-04 | 2015-08-20 | Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" | Трансдермальный седативный фармацевтический гель для лечения психоэмоциальных расстройств |
CA2906796A1 (en) * | 2013-03-15 | 2014-09-25 | Nal Pharmaceuticals Ltd. | Transdermal drug delivery system containing rivastigmine |
AR095259A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
TWI626953B (zh) * | 2013-06-12 | 2018-06-21 | Km Transderm Ltd | Percutaneous absorption preparation |
WO2014200072A1 (ja) | 2013-06-12 | 2014-12-18 | 株式会社 ケイ・エム トランスダーム | 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤 |
CN105358139B (zh) | 2013-07-03 | 2020-10-16 | Lts罗曼治疗方法有限公司 | 具有电子元件的经皮治疗系统 |
KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
RU2646512C2 (ru) | 2013-10-07 | 2018-03-05 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Устройства для трансдермальной доставки дексмедетомидина и способы их применения |
ES2847936T3 (es) | 2013-10-07 | 2021-08-04 | Teikoku Pharma Usa Inc | Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina |
TWI629066B (zh) | 2013-10-07 | 2018-07-11 | 帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
EP3081211A4 (en) | 2013-12-12 | 2017-10-11 | Hisamitsu Pharmaceutical Co., Inc. | Patch with cover member and patch kit with cover member |
CN103877063A (zh) * | 2014-03-24 | 2014-06-25 | 张绪伟 | 一种重酒石酸卡巴拉汀胶囊及其制备方法 |
US9949935B2 (en) | 2014-04-08 | 2018-04-24 | Teikoku Pharma Usa, Inc. | Rivastigmine transdermal compositions and methods of using the same |
WO2015174502A1 (ja) | 2014-05-15 | 2015-11-19 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
CA2948219C (en) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
CN106456566B (zh) | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
EP4238580A3 (en) | 2014-05-20 | 2023-10-25 | LTS Lohmann Therapie-Systeme AG | Transdermal delivery system including an interface mediator |
WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
CN104523656A (zh) * | 2014-11-20 | 2015-04-22 | 美吉斯制药(厦门)有限公司 | 一种卡巴拉汀缓释透皮贴剂及其制备方法 |
DE102015107743A1 (de) | 2015-05-18 | 2016-11-24 | Bsn Medical Gmbh | Silikongelbeschichtete adhäsive Schichtstruktur |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
RU2018133932A (ru) | 2016-04-01 | 2020-05-12 | Терапьютиксмд, Инк. | Фармацевтическая композиция стероидного гормона |
US9980921B2 (en) * | 2016-06-30 | 2018-05-29 | Taho Pharmaceuticals Ltd. | Transdermal delivery system containing methylphenidate or its salts and methods thereof |
JP6864968B2 (ja) | 2016-08-22 | 2021-04-28 | 救急薬品工業株式会社 | 貼付剤 |
JP7236389B2 (ja) * | 2016-12-20 | 2023-03-09 | エルテーエス ローマン テラピー-ジステーメ アーゲー | アセナピンを含有する経皮治療システム |
AU2017384392B2 (en) | 2016-12-20 | 2023-05-25 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
KR102033686B1 (ko) * | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
US11389421B2 (en) | 2017-09-05 | 2022-07-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of rivastigmine |
BR112020018607A2 (pt) * | 2018-03-13 | 2020-12-29 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone acrílico |
WO2019175106A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
EP3764998A1 (en) * | 2018-03-13 | 2021-01-20 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
EP3810101A1 (en) | 2018-06-19 | 2021-04-28 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing rivastigmine |
BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
KR102590643B1 (ko) | 2019-01-31 | 2023-10-17 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
JP2022540442A (ja) * | 2019-07-09 | 2022-09-15 | エルテーエス ローマン テラピー-ジステーメ アーゲー | シリコーン含有ポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム |
BR112021023509A2 (pt) * | 2019-07-09 | 2022-01-18 | Lts Lohmann Therapie Systeme Ag | Sistema terapêutico transdérmico compreendendo uma camada contendo o agente ativo compreendendo um polímero acrílico e uma camada de contato com a pele compreendendo um adesivo de gel de silicone |
CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US5252335A (en) * | 1989-07-12 | 1993-10-12 | Cygnus Therapeutic Systems | Transdermal administration of lisuride |
DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
US6316023B1 (en) | 1998-01-12 | 2001-11-13 | Novartis Ag | TTS containing an antioxidant |
GB9800526D0 (en) * | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
WO2001032115A1 (en) * | 1999-11-04 | 2001-05-10 | Xel Herbaceuticals | Transdermal administration of huperzine |
US20020192243A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
AU2002235155A1 (en) * | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
DE10103860B4 (de) | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
WO2003020289A1 (en) * | 2001-08-30 | 2003-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors |
DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
DK1509232T3 (da) * | 2002-05-31 | 2009-02-23 | Lundbeck & Co As H | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom |
PL376476A1 (en) * | 2002-10-24 | 2005-12-27 | Merz Pharma Gmbh & Co.Kgaa | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
JP2007523121A (ja) | 2004-02-19 | 2007-08-16 | ノバルティス アクチエンゲゼルシャフト | 血管性鬱病の処置のためのコリンエステラーゼ阻害剤の使用 |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
EP2596889B1 (en) * | 2011-11-23 | 2017-04-26 | Sandvik Intellectual Property AB | A cutting insert and a milling tool |
-
2006
- 2006-10-05 TW TW095137245A patent/TWI389709B/zh not_active IP Right Cessation
- 2006-10-10 SG SG2014014989A patent/SG2014014989A/en unknown
- 2006-10-10 CN CNA2006800434220A patent/CN101312717A/zh active Pending
- 2006-10-10 NZ NZ568273A patent/NZ568273A/en unknown
- 2006-10-10 KR KR1020227039266A patent/KR20220156666A/ko not_active Application Discontinuation
- 2006-10-10 EP EP10179085.5A patent/EP2292219B9/en not_active Revoked
- 2006-10-10 WO PCT/US2006/039557 patent/WO2007064407A1/en active Application Filing
- 2006-10-10 KR KR1020087013112A patent/KR20080071581A/ko not_active Application Discontinuation
- 2006-10-10 AR ARP060104447A patent/AR057152A1/es not_active Application Discontinuation
- 2006-10-10 SI SI200631618T patent/SI2292219T1/sl unknown
- 2006-10-10 KR KR1020217001087A patent/KR20210008440A/ko not_active Application Discontinuation
- 2006-10-10 PL PL10179085T patent/PL2292219T4/pl unknown
- 2006-10-10 DE DE202006021172U patent/DE202006021172U1/de not_active Ceased
- 2006-10-10 CA CA002563110A patent/CA2563110A1/en active Pending
- 2006-10-10 JP JP2008543278A patent/JP2009517468A/ja not_active Withdrawn
- 2006-10-10 CN CN2011100034841A patent/CN102048713A/zh active Pending
- 2006-10-10 MY MYPI20081730 patent/MY151020A/en unknown
- 2006-10-10 BR BRPI0619758-2A patent/BRPI0619758A2/pt not_active Application Discontinuation
- 2006-10-10 KR KR1020187012945A patent/KR20180050441A/ko active Search and Examination
- 2006-10-10 EP EP06816633A patent/EP1959937A1/en not_active Withdrawn
- 2006-10-10 US US11/539,979 patent/US20070128263A1/en not_active Abandoned
- 2006-10-10 EP EP10179084A patent/EP2286802A1/en not_active Withdrawn
- 2006-10-10 EP EP17155300.1A patent/EP3235495A1/en not_active Ceased
- 2006-10-10 AU AU2006320919A patent/AU2006320919B2/en active Active
- 2006-10-10 EP EP20140163637 patent/EP2786748A1/en not_active Ceased
- 2006-10-10 KR KR1020137031255A patent/KR20130143729A/ko not_active Application Discontinuation
- 2006-10-10 ES ES10179085T patent/ES2414455T3/es active Active
- 2006-10-10 BR BRBR122013013162-0A patent/BR122013013162A2/pt not_active Application Discontinuation
- 2006-10-10 KR KR1020147010333A patent/KR20140072108A/ko not_active Application Discontinuation
- 2006-10-10 RU RU2008126459/15A patent/RU2450805C2/ru active
- 2006-10-10 DE DE14163637.3T patent/DE14163637T1/de active Pending
- 2006-10-10 DK DK10179085.5T patent/DK2292219T3/da active
- 2006-10-10 PT PT101790855T patent/PT2292219E/pt unknown
- 2006-10-10 KR KR1020177006994A patent/KR20170033449A/ko not_active Application Discontinuation
-
2008
- 2008-05-07 ZA ZA200803882A patent/ZA200803882B/xx unknown
- 2008-05-07 IL IL191311A patent/IL191311A/en active IP Right Grant
- 2008-05-20 MY MYPI2013003893A patent/MY162986A/en unknown
- 2008-05-26 EC EC2008008469A patent/ECSP088469A/es unknown
- 2008-05-28 GT GT200800075A patent/GT200800075A/es unknown
- 2008-05-30 TN TNP2008000238A patent/TNSN08238A1/en unknown
- 2008-06-02 MA MA30991A patent/MA30022B1/fr unknown
- 2008-06-18 NO NO20082753A patent/NO20082753L/no unknown
- 2008-10-16 AT AT0059308U patent/AT11185U1/de not_active IP Right Cessation
- 2008-12-19 HK HK11107634.4A patent/HK1153646A1/xx unknown
-
2013
- 2013-01-31 DK DK201300015U patent/DK201300015Y4/da not_active IP Right Cessation
- 2013-01-31 DK DKBA201300014U patent/DK201300014U3/da not_active IP Right Cessation
- 2013-04-12 DK DKBA201300059U patent/DK201300059U3/da not_active IP Right Cessation
- 2013-04-19 PH PH12013500771A patent/PH12013500771A1/en unknown
- 2013-04-19 PH PH12013500772A patent/PH12013500772B1/en unknown
- 2013-05-21 JP JP2013107198A patent/JP5938612B2/ja active Active
- 2013-05-31 US US13/906,922 patent/US20130266633A1/en not_active Abandoned
-
2014
- 2014-01-21 US US14/159,609 patent/US20140134230A1/en not_active Abandoned
- 2014-07-24 AR ARP140102752A patent/AR097045A2/es not_active Application Discontinuation
- 2014-08-25 IL IL234291A patent/IL234291A/en active IP Right Grant
- 2014-08-28 IL IL234364A patent/IL234364A/en active IP Right Grant
-
2015
- 2015-11-30 JP JP2015233544A patent/JP6298034B2/ja active Active
-
2016
- 2016-10-07 DK DKBA201600113U patent/DK201600113Y4/da not_active IP Right Cessation
-
2017
- 2017-02-23 IL IL250734A patent/IL250734A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250734A0 (en) | Transdermal therapeutic system | |
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
SI3424932T1 (sl) | Boronoftalidi za terapevtsko uporabo | |
GB0526291D0 (en) | Therapeutic method | |
GB0509326D0 (en) | Therapeutic compounds | |
GB0509573D0 (en) | Therapeutic compounds | |
GB0515140D0 (en) | Therapeutic device | |
GB0522881D0 (en) | Therapeutic compounds | |
GB0509405D0 (en) | Therapeutic compounds | |
GB0513747D0 (en) | Therapeutic compounds | |
ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
GB0507003D0 (en) | Therapeutic | |
GB0518235D0 (en) | Therapeutic compounds | |
GB0518720D0 (en) | Therapeutic combination | |
GB0501655D0 (en) | Therapeutic use | |
ZA200710418B (en) | Solid transdermal therapeutic system comprising UV absorber | |
GB0722015D0 (en) | Transdermal therapy | |
GB0515580D0 (en) | Therapeutic compounds | |
GB0511259D0 (en) | Therapeutic utrasound system | |
GB0622285D0 (en) | Transdermal therapy | |
GB0501657D0 (en) | Therapeutic use | |
GB0518537D0 (en) | Therapeutic use | |
GB0509932D0 (en) | Therapeutic method | |
GB0521547D0 (en) | Therapeutic method | |
GB0521540D0 (en) | Therapeutic method |